Archives
|
Entry
|
Blogger
|
Date
|
Location
|
|
Eastbourne Capital Dumps Entire Stake in Amylin After Partial Victory in Proxy Battle
|
Luke Timmerman |
10/09/09 |
San Diego
|
|
Amylin CEO, Putting Boardroom Coup Behind Him, Turns Up Heat on New Diabetes Drug
|
Luke Timmerman |
09/29/09 |
San Diego
|
|
Elan Breached Tysabri Partnership With Biogen Idec, Federal Judge Says
|
Luke Timmerman |
09/04/09 |
Boston
|
|
Pickett to Relinquish Biogen Idec Board Seat, New Financing for iWalk, Genocea Goes After Vaccine Market, & More Boston-Area Life Sciences News
|
Rebecca Zacks |
09/02/09 |
Boston
|
|
Biogen Idec Research Boss Quits Board, Giving Icahn Shot at Pushing R&D Agenda
|
Luke Timmerman |
08/26/09 |
Boston
|
|
In Aftermath of Proxy Fight Amylin Pharmaceuticals Investor Expresses Concern Over Empty Board Chair Seat
|
Bruce V. Bigelow |
08/07/09 |
San Diego
|
|
Elan Hits Biogen Idec with Lawsuit to Protect Tysabri Deal with J&J
|
Ryan McBride |
08/06/09 |
Boston
|
|
VC Biotech Funding Rebounds, Biogen Idec Co-Founder Resigns From Board, Pathway Genomics Debuts $250 Personal Genome Test, & More San Diego Life Sciences News
|
Bruce V. Bigelow |
07/23/09 |
San Diego
|
|
Replacing Phil Sharp Will Be Up to Biogen’s Board
|
Ryan McBride |
07/20/09 |
Boston
|
|
Biotech Pioneer Phillip Sharp Retires from Biogen Idec Board
|
Ryan McBride |
07/16/09 |
Boston
|
|
Icahn Bags Two Biogen Board Seats, Pharma Giants Add $40M to Aileron Coffers, Pulmatrix Proceeds With Tests of Flu-Blocking Aerosol, & More Boston-Area Life Sciences News
|
Rebecca Zacks |
06/10/09 |
Boston
|
|
Biogen Idec Confirms Second Icahn Pick Elected to Board of Directors
|
Robert Buderi |
06/09/09 |
Boston
|
|
Exclusive: Icahn’s Picks For Biogen Idec Board on Why They Think They Won 2 Seats, Who’s Likely Out, and Plans for the Future
|
Robert Buderi |
06/04/09 |
Boston
|
|
Amylin Dissidents Win Board Seats, Targeted Genetics’ Troubles Raise Gene Therapy Concerns, Celladon Eyes Partnership, & More San Diego Life Sciences News
|
Bruce V. Bigelow |
06/04/09 |
San Diego
|
|
Icahn Nominees Claim Victory on Two of Four Open Seats to Biogen Idec Board, Vote Still Not Official
|
Roxanne Palmer |
06/03/09 |
Boston
|
|
Inside the Biogen Idec Shareholder Meeting, Tensions Flare as Icahn Accuses Company of “Hijacking” Vote
|
Roxanne Palmer |
06/03/09 |
Boston
|
|
Contentious Biogen Idec Meeting Delayed; Icahn Nominee Objects, Saying “This is Not North Korea”
|
Luke Timmerman |
06/03/09 |
Boston
|
|
Biogen Idec Showdown with Carl Icahn Culminates in Shareholder Vote Today
|
Luke Timmerman |
06/03/09 |
Boston
|
|
Amylin Founder Ted Greene, In Exclusive Interview, Upbeat About Outcome of Proxy Battle
|
Bruce V. Bigelow |
06/02/09 |
San Diego
|
|
Amylin Chairman, Lead Director Ousted as Dissidents Gain Two Board Seats
|
Luke Timmerman |
06/02/09 |
San Diego
|
|
Amylin Pharmaceuticals Gets New Directors (But Who Are They?), Ophthonix and Vical Raise Capital, Metabasis Cuts Back—Again, & More San Diego Life Sciences News
|
Bruce V. Bigelow |
05/28/09 |
San Diego
|
|
Genentech Veteran Takes Agios’ Helm, E8 and MIT Take on Navigenics, Genzyme’s Mipomersen Takes Next Step, Alnylam Takes Advantage of Tekmira Technology, & More Boston-Area Life Sciences News
|
Rebecca Zacks |
05/28/09 |
Boston
|
|
Amylin’s Dissident Shareholders Gain Influence on Board
|
Bruce V. Bigelow |
05/27/09 |
San Diego
|
|
Amylin Shareholders Vote Today in Battle to Influence Board
|
Bruce V. Bigelow |
05/27/09 |
San Diego
|
|
Icahn Wins Key Endorsement In Proxy Fight With Biogen Idec
|
Luke Timmerman |
05/26/09 |
Boston
|
|
Shareholder Showdown at Amylin Headquarters
|
Juha-Pekka Tikka |
05/26/09 |
San Diego
|
|
Biogen Idec Rebuts Icahn Attack, GlaxoSmithKline Quietly Spins Off Tempero Pharmaceuticals, Knome Launches Cheaper Sequencing Service, & More Boston-Area Life Sciences News
|
Rebecca Zacks |
05/20/09 |
Boston
|
|
Icahn Wants to Fix Amylin First, Not Sell on the Cheap, Alex Denner Says
|
Luke Timmerman |
05/19/09 |
San Diego
|
|
Amylin Dissidents Win More Support
|
Luke Timmerman |
05/18/09 |
San Diego
|
|
Amylin Co-Founder Ted Greene Explains His Switch in Proxy Battle
|
Bruce V. Bigelow |
05/18/09 |
San Diego
|
|
Page 1 of
4 |
next page » |
Business, life sciences, and technology news — covering Boston, Seattle, San Diego, and beyond.
© 2007-2009, Xconomy, Inc.
XCONOMY is a registered service mark of Xconomy, Inc.
All rights reserved.
Site designed by
Matthew Bouchard, produced by
Andrew Koyfman,
and powered by WordPress.
